This multicentre , double-blind , active-controlled study randomized @ patients aged @-@ years to @ weeks of treatment with metformin in addition to alogliptin @ mg once daily ( n = @ ) , alogliptin @ mg once daily ( n = @ ) or glipizide @ mg once daily , titrated to a maximum of @ mg ( n = @ ) .